Progressive Care (OTCQB: RXMD), a personalized healthcare services and technology provider, and its wholly owned subsidiary PharmcoRx Pharmacy, are expanding their in-pharmacy offerings. The expansion comes as the result of an agreement with the Mark Cuban Cost Plus Drug Company (“MCCPDC”), which offers a Cost Plus Drugs program that gives participating patients the ability to purchase both generic and branded medicines at cost plus a low fixed markup. According to the announcement, the program includes more than 1,000 drugs, offered at actual acquisition cost plus a 15% markup. MCCPDC recently unveiled its Team Cuban Card, which is a free prescription benefit program designed to provide consumers around the country with low-cost medications. Based on the agreement, PharmcoRx locations will be a participating pharmacy in the program and will be listed in the Team Cuban Card provider directory. “Through our inclusion in the Team Cuban Card provider network, we are quickly able to expand our PharmcoRx pharmacy offerings by providing consumers with increased access to medications at a significantly reduced cost,” said Progressive Care chief operating officer Pamela Roberts in the press release. “By partnering with organizations such as the Mark Cuban Cost Plus Drug Company and our ongoing initiatives to expand our pharmacy service offerings and reach, we are continuing our mission to make positive contributions to the health of our customers.”
To view the full press release, visit https://ibn.fm/gDRW7
About Progressive Care Inc.
Progressive Care, through its subsidiaries, is a Florida health services organization and provider of third-party administration (“TPA”), data management, COVID-19-related diagnostics and vaccinations, 340B contracted pharmacy services, prescription pharmaceuticals, compounded medications, provider of telepharmacy services, the sale of anti-retroviral medications, medication therapy management (“MTM”), the supply of prescription medications to long-term care facilities, and health practice risk management. Progressive Care became a subsidiary of NextPlat Corp. (NASDAQ: NXPL) on July 1, 2023. For more information about the company, visit www.ProgressiveCareUS.com
NOTE TO INVESTORS: The latest news and updates relating to RXMD are available in the company’s newsroom at https://ibn.fm/RXMD
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
InvestorWire is powered by IBN